Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)

NCT03900468 is registered in ClinicalTrials.gov with MedtronicNeuro as lead sponsor.

NCT NCT03900468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03900468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)
Lead sponsor
MedtronicNeuro
Phase
Not applicable
Overall status
Terminated
Start date
March 5, 2020
Completion date
February 26, 2026
Enrollment
29 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy